SPONSOR
Verrica Pharmaceuticals Inc.
Total Trials
2
Recruiting
2
Phases
Phase 3
Verrica Pharmaceuticals Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (HPV), Warts.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Verrica Pharmaceuticals Inc.
How many clinical trials has Verrica Pharmaceuticals Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Verrica Pharmaceuticals Inc., of which 2 are actively recruiting participants. These trials cover conditions including Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (HPV). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Verrica Pharmaceuticals Inc. research focus on?
Verrica Pharmaceuticals Inc. clinical trials span Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (HPV), Warts. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Verrica Pharmaceuticals Inc. clinical trial?
To participate in a Verrica Pharmaceuticals Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Verrica Pharmaceuticals Inc. trials with current recruitment status updated daily.
Clinical Trials by Verrica Pharmaceuticals Inc.
NCT07246590 Phase 3
Recruiting
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
Common Warts
NCT07457918 Phase 3
Recruiting
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
Common Warts (Verruca Vulgaris)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology